SynthesisInternational journal of molecular sciences2026
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis.
Filippo Frioni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.